Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial

AIMS: In this analysis, we utilized data from PARADIGM‐HF to test the hypothesis that participants who exhibited any dose reduction during the trial would have similar benefits from lower doses of sacubitril/valsartan relative to lower doses of enalapril. METHODS AND RESULTS: In a post‐hoc analysis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Heart Fail
Autori principali: Vardeny, Orly, Claggett, Brian, Packer, Milton, Zile, Michael R., Rouleau, Jean, Swedberg, Karl, Teerlink, John R., Desai, Akshay S., Lefkowitz, Martin, Shi, Victor, McMurray, John J.V., Solomon, Scott D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2016
Soggetti:
Medical Treatment
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5095784/
https://ncbi.nlm.nih.gov/pubmed/27283779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.580
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi